A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study
- Tadaaki Yamada
- , Yasuhiro Goto
- , Hiroshi Tanaka
- , Hideharu Kimura
- , Koichi Minato
- , Hiroshi Gyotoku
- , Takeshi Honda
- , Satoshi Watanabe
- , Kenji Morimoto
- , Fumiaki Kiyomi
- , Junji Uchino
- , Koichi Takayama
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
20
リンクは新しいタブで開きます
被引用数
(Scopus)